Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2003
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645957 Useful in preventing and treating allergic immunological diseases; treating asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis
11/11/2003US6645594 Formazan metal complex
11/11/2003CA2143756C N-cyano-n'-pyridylguanidines as serotonin antagonists
11/11/2003CA2052800C Aryl sulphide, aryl sulphoxide and aryl sulphone compounds and processes for their preparation
11/06/2003WO2003091688A2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091262A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091228A2 Method for producing substituted phenylsulfonyl urea
11/06/2003WO2003091217A1 Pyridine compounds or salts thereof and herbicides containing the same
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090674A2 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
11/06/2003WO2003068183A8 Sunscreen compositions as well as dihydropyridines and dihydropyranes
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002064567A3 Substituted carboxamides as inhibitors of factor xa
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030208081 Carbocyclic ethers such as (Methyl-(3-(4-phenoxy-phenoxy)-3-phenyl-propyl)-amino)-acetic acid, used as neurotransmitter antagonists, for prophylaxis of psychological disorders
11/06/2003US20030208075 Process for making chiral 1,4-disubstituted piperazines
11/06/2003US20030208067 Inhibitors of protein kinase for the treatment of disease
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207920 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
11/06/2003US20030207914 For treatment of tumors and/or cancerous cell growth mediated by raf kinase
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207872 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
11/06/2003US20030207870 Aryl ureas with angiogenisis inhibiting activity
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207857 Phenyl heterocyclyl ethers
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003US20030207153 Luminescent device with a triarylamine compound
11/06/2003US20030205707 Electroluminescent materials
11/06/2003CA2484035A1 Pyridine compounds or salts thereof and herbicides containing the same
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483192A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/06/2003CA2449740A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
11/05/2003EP1359147A1 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and processes for making the same
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358179A1 Synthesis method and intermediates of pyridin-2-yl-methylamine
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358160A1 Aminal diones as potassium channel openers
11/05/2003EP1358159A1 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof
11/05/2003EP1357889A1 Novels couplers for use in oxidative hair dyeing
11/05/2003EP1165494B1 Hsv primase inhibitors
11/05/2003EP1159270B1 Method of preparing 1-(6-methylpyridine-3-yl)-2- 4-(methylsulfonyl)phenyl ethanone
11/05/2003EP1072584B1 Amine derivative fixed to resin and method for synthesizing beta-aminocarbonyl compound in a solid phase
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003CN1454206A 2-enamino-cetonitriles substitues par phenyle
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454195A Process for fluorinating aromatic ring compounds
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453269A Prepn of pyrido-phenylurea
11/05/2003CN1126742C Fungicides compound
11/04/2003US6642387 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active β3 agonist by the use of the same
11/04/2003US6642260 Nitric oxide donors and pharmaceutical compositions containing them
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003US6642215 Using cyanoguanidine compound; anticancer agents
11/04/2003US6641871 Electrooptical display
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
10/2003
10/30/2003WO2003089414A1 Amlodipine nicotinate and process for the preparation thereof
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088966A1 The use of hydroxypyridone-derivatives in wound healing
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003040149A3 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
10/30/2003WO2003032921A3 Treatment of neurodegenerative diseases and cancer of the brain
10/30/2003WO2003026415A3 Insecticidal diamides
10/30/2003WO2002085458A3 Use of nk-1 receptor antagonists against benign prostatic hyperplasia
10/30/2003WO2002066425A3 Compositions and methods for hydration of terminal alkynes
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204087 Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 633